NICA BTA logo

Nanologica OM:NICA BTA Stock Report

Last Price

kr5.95

Market Cap

kr282.7m

7D

-8.5%

1Y

n/a

Updated

09 Apr, 2024

Data

Company Financials +

NICA BTA Stock Overview

Nanologica AB (publ), a nanotechnology company, develops, manufactures, and sells nanoporous silica particles for life science applications worldwide.

NICA BTA fundamental analysis
Snowflake Score
Valuation2/6
Future Growth2/6
Past Performance0/6
Financial Health2/6
Dividends0/6

Nanologica AB (publ) Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Nanologica
Historical stock prices
Current Share Pricekr5.95
52 Week Highkr7.00
52 Week Lowkr3.80
Beta0.64
1 Month Changen/a
3 Month Changen/a
1 Year Changen/a
3 Year Changen/a
5 Year Changen/a
Change since IPO56.58%

Recent News & Updates

Recent updates

Shareholder Returns

NICA BTASE BiotechsSE Market
7D-8.5%-0.9%-1.2%
1Yn/a-5.8%8.3%

Return vs Industry: Insufficient data to determine how NICA BTA performed against the Swedish Biotechs industry.

Return vs Market: Insufficient data to determine how NICA BTA performed against the Swedish Market.

Price Volatility

Is NICA BTA's price volatile compared to industry and market?
NICA BTA volatility
NICA BTA Average Weekly Movementn/a
Biotechs Industry Average Movement9.8%
Market Average Movement6.1%
10% most volatile stocks in SE Market12.8%
10% least volatile stocks in SE Market3.5%

Stable Share Price: NICA BTA's share price has been volatile over the past 3 months.

Volatility Over Time: Insufficient data to determine NICA BTA's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
200416Andreas Bhagwaniwww.nanologica.com

Nanologica AB (publ), a nanotechnology company, develops, manufactures, and sells nanoporous silica particles for life science applications worldwide. The company operates through two segments, Drug Development and Chromatography. It offers NLAB Saga, a new generation silica for preparative chromatography; and SVEA (U)HPLC analytical columns.

Nanologica AB (publ) Fundamentals Summary

How do Nanologica's earnings and revenue compare to its market cap?
NICA BTA fundamental statistics
Market capkr282.74m
Earnings (TTM)-kr75.16m
Revenue (TTM)kr4.67m

60.5x

P/S Ratio

-3.8x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
NICA BTA income statement (TTM)
Revenuekr4.67m
Cost of Revenuekr4.75m
Gross Profit-kr76.00k
Other Expenseskr75.08m
Earnings-kr75.16m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

Apr 26, 2024

Earnings per share (EPS)-1.70
Gross Margin-1.63%
Net Profit Margin-1,608.67%
Debt/Equity Ratio-3,517.2%

How did NICA BTA perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.